Animal Biotechnology Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented by Product Type (Diagnostic Tests, Reproductive & Genetic Products, Vaccines and Drugs), Application and Geography

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

A significant rise in focus toward cloning and transgenic animals is expected to propel the market growth. The Annual Statistics of Scientific Procedures on Living Animals Great Britain 2017, published by the UK Government, states that in 2017, 3.79 million procedures were carried out in the United Kingdom involving living animals, out of which, 1.89 million were carried out for experimental purposes, and 1.90 million were counted under the breeding of genetically altered animals. As per the report published by the US Food and Drug Administration (FDA), in 2017, scientists have successfully cloned many livestock species, such as cattle, swine, sheep, and goats. Globally, animal cloning has gained popularity and acceptance, as a method to produce genetically identical animals, which is expected to fuel the market growth.

In addition to the aforementioned factor, increasing R&D activities by major market players, and the rising regulatory approvals are expected to propel the market growth over the forecast period.

Scope of the Report

As per the scope of the report, Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications.

By Product Type
Diagnostic Tests
Reproductive & Genetic Products
Vaccines
Drugs
By Application
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccines Segment is Expected to Show Better Growth over the Forecast Period

Based on Product Type, it is segmented into Diagnostic Tests, Reproductive & Genetic Products, Vaccines, and Drugs. The growth of the vaccine segment is mainly attributed to the rising burden of animal diseases. These diseases are naturally transmitted from animals to humans, due to the consumption of contaminated food and water or by direct contact with infected animals or humans. Vaccination is an effective way to reduce disease burden in animals and plays an important role in preventive health and disease control. According to Veterinary Cancer Society estimates, every year more than 6 million cats and dogs are diagnosed with cancer in the United States. Moreover, the increasing demand for meat and animal-based products, rising pet adoption and increasing awareness regarding animal health are expected to fuel the growth of the vaccine segment over the forecast period.

To understand key trends, Download Sample Report

North America is Expected to Dominate the Animal Biotechnology Market

North America is expected to dominate the animal biotechnology market over the forecast period, owing to the factors, such as the increasing animal meat consumption, growing prevalence of various animal diseases, and the rising animal healthcare expenditure. The data published by the American Pet Products Association, in 2018, states that the total pet healthcare expenditure has been estimated to be USD 72.13 billion, while that in 2017 was found to be USD 69.51 billion. In addition, the growing awareness about animal health among the pet owners, rising government initiatives, and rise in product innovation (such as new vaccine launches) are some other factors propelling the growth of the animal biotechnology market in North America.

To understand geography trends, Download Sample Report.

Competitive Landscape

The global players into the animal biotechnology market are Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, Ivaoes, LLC, Merck & Co.,Inc., Pfizer Inc., Santa Cruz Biotechnology, Inc., Virbac and Zoetis Inc.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Activities by Major Market Players

      2. 4.2.2 Growing Focus Towards Cloning & Transgenic Animals

    3. 4.3 Market Restraints

      1. 4.3.1 Ethical Issues Associated with Animal Biotechnology Products

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Diagnostic Tests

      2. 5.1.2 Reproductive & Genetic Products

      3. 5.1.3 Vaccines

      4. 5.1.4 Drugs

    2. 5.2 By Application

      1. 5.2.1 Development of Animal Pharmaceuticals

      2. 5.2.2 Food Safety and Drug Development

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Biogenesis Bago

      3. 6.1.3 Boehringer Ingelheim GmbH

      4. 6.1.4 Ivaoes, LLC

      5. 6.1.5 Merck & Co.,Inc.

      6. 6.1.6 Pfizer Inc.

      7. 6.1.7 Santa Cruz Biotechnology, Inc.

      8. 6.1.8 Virbac

      9. 6.1.9 Zoetis Inc.

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports